Insulin- and glucose metabolism
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Healthy study participants; BMI 18,0-28,0 kg/m²; written consent after information about study contents and study procedure; ability and willingness of study participants to follow study leaders instructions
Exclusion criteria
Exclusion criteria: Smokers; high performance athlete; hormonal illnesses (hyperthyroidism e.g.); acute potassium and magnesium deficiencies; severe chronic illness (Cancer, diabetes mellitus Typ I e.g.) manifest coronary heart disease(angina pectoris, heart failure e.g.), kidney insufficiency or liver diseases; chronic gastroinestinal diseases (colitis ulcerosa, morbus crohn, pancreas insuffiency); known endocrine and immunological diseases; familial diabetes mellitus; treatment with not-insulinreleasing antidiabetics (guar, ascarbose e.g.); chronic intake of corticosteroids (except inhalativ) and psychotropic drugs, intolerances or allergies regarding study product ingredientes; regular intake of laxatives; pregnancy and lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glycemic Index (Parameter: Glucose and Insulin in Blood); Subjective Satiety (Questionnaire) Blood draw and determination of satiety at time point 0 (Start), 15 min (after start), 30 min (after start), 45 min (after start), 60 min (after start), 90 min (after start) and 120 min (after start) | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes of fasting glucose and insulin; general information about health status; drug intake; anthropometric data: height, weight; security parameter (creatinin, uric acid, liver parameter) | — |
Countries
Germany
Contacts
Institut für Lebensmittelwissenschaft und Humanernährung